ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag evolution genomics art science funding

Speaking of Science
The Scientist | Jan 1, 2012 | 2 min read
January 2012's selection of notable quotes
Illustration of scientists
Opinion: How Large International Collaborations Have Fared in the Pandemic
Sadye Paez, Giulio Formenti, and Erich D. Jarvis | May 2, 2022 | 5 min read
COVID-19 has challenged the progress of Big Science. Here are the lessons learned.
Illustration showing a puzzle piece of DNA being removed
Large Scientific Collaborations Aim to Complete Human Genome
Brianna Chrisman and Jordan Eizenga | Sep 1, 2022 | 10+ min read
Thirty years out from the start of the Human Genome Project, researchers have finally finished sequencing the full 3 billion bases of a person’s genetic code. But even a complete reference genome has its shortcomings.
Plant genomics gets $100 million infusion
Charles Choi(cqchoi@nasw.org) | Oct 7, 2003 | 3 min read
New NSF-funded virtual centers created to cultivate speedy collaboration
Sequencing Stakes: Celera Genomics Carves Its Niche
Ricki Lewis | Jul 18, 1999 | 8 min read
J. Craig Venter is no stranger to contradiction and controversy. He seems to thrive on it. In 1991, when the National Institutes of Health was haggling over patenting expressed sequence tags (ESTs)--a shortcut to identifying protein-encoding genes--Venter the inventor accepted a private offer to found The Institute for Genomic Research (TIGR) in Rockville, Md. TIGR would discover ESTs and give most of them to a commercial sibling, Human Genome Sciences (HGS), to market. ESTs are now a standard
Genome Investigator Craig Venter Reflects On Turbulent Past And Future Ambitions
Karen Young Kreeger | Jul 23, 1995 | 8 min read
And Future Ambitions Editor's Note: For the past four years, former National Institutes of Health researcher J. Craig Venter has been a major figure in the turbulent debates and scientific discoveries surrounding the study of genes and genomes. Events heated up in 1991, when NIH attempted to patent gene fragments, which were isolated using Venter's expressed sequence tag (EST)/complementary DNA (cDNA) approach for discovering human genes (M.A. Adams et al., Science, 252:1651-6, 1991). NIH's mo
The Genome Project Holds Promise, But We Must Look Before We Leap
Joshua Lederberg | Mar 19, 1989 | 3 min read
To an ever-increasing degree, explanation in biology is reduced to art expression in the language of DNA sequences. At least, a necessary condition for the interpretation of many problems in evolution, genetics, virology, immunology teratology, or cancer is the elucidation of a message in the well-known ATGC alphabet. Furthermore, the power of biotechnology rests on manufacturing blueprints of the same ilk. To a degree " unprecedented in biological history, we can describe the agenda for much
The Human Genome
Arielle Emmett | Jul 23, 2000 | 10+ min read
Life sciences took center stage virtually around the world June 26. President Bill Clinton, flanked on the left by Celera Genomics Group president J. Craig Venter and on the right by National Human Genome Research Institute director Francis S. Collins, announced the completion of "the first survey of the entire human genome."
Privatizing the Human Genome?
Paul Smaglik | Jun 7, 1998 | 10 min read
Principals behind joint-venture proposal and public effort seek to define relationships A private effort to sequence the human genome four years ahead of the Human Genome Project's 2005 goal could either compete directly with the federal project or meld seamlessly with it. Before any relationship between the two efforts becomes formalized, scientists and federal officials involved with the Human Genome Project must determine whether the private approach will work, who will own the data, how qu
A Personal View of Genomics
Ricki Lewis | Nov 25, 2001 | 6 min read
It wasn't easy getting to the 4th International Meeting on Single Nucleotide Polymorphisms and Complex Genome Analysis held Oct. 10-15 at the Wenner-Gren Foundation in Stockholm. A week earlier, as flight cancellations continued in the wake of the Sept. 11 terrorist attacks, SwissAir had declared bankruptcy and an SAS jet had crashed in Milan, further disrupting schedules. So it was little surprise that several speakers had to phone in their talks. But not J. Craig Venter, president and chief sc

Run a Search

ADVERTISEMENT